NanoVibronix
NAOV | NASDAQ
$1.90
+$0.02 (+1.06%)
At close: Mar 11, 2026, 09:30 AM ET
+1.06%
(1D)Rating
Key Statistics
Market Data
Market Cap $1.51M
1D Range
1.78 1.92
52W Range
1.05 162.50
Valuation (TTM)
PE -0.07
PB 0.05
EV/EBITDA 0.46
Valuation (NTM)
Forward PE N/A
Forward PEG -0.00
Price Target N/A
Cash Flow
FCF Yield -775.6%
SBC Adj. FCF Yield -910.9%
SBC Impact -17.4%
Margins
Gross Margin -26.1%
Operating Margin -1362.7%
FCF Margin -609.8%
Growth (CAGR)
Revenue 3Y | 5Y 44.1% |
23.9%
Dil EPS 3Y | 5Y -39.6% |
40.8%
FCF 3Y | 5Y -70.2% |
-21.5%
Returns
ROA -63.2%
ROE -69.9%
ROIC -84.0%
Financial Health
Net Cash
$854K
Current Ratio 0.66
Interest Coverage 96.14
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd., develops and commercializes innovative, non-invasive devices that stimulate biological responses for therapeutic purposes. Their...
Sector Healthcare
Industry Medical - Devices
Employees 31
IPO Date May 28, 2015
Website www.nanovibronix.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove NAOV